Idorsia has extended its cash runway into 2025 via an exclusivity fee for global rights negotiations for Tryvio.

In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new ...

Acadia Pharmaceuticals has secured an exclusive global licence from Saniona to develop and commercialise SAN711.

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.